Related Experiment Videos
Midazolam premedication in paediatric anaesthesia
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|November 22, 1986
Summary
Midazolam is an effective pediatric premedication, improving pre-anesthesia behavior without delaying recovery. This study compared midazolam, TDM, and no sedation in children, finding midazolam superior for managing anxiety.
Area of Science:
- Pediatric Anesthesiology
- Pharmacology
Background:
- Premedication in pediatric anesthesia is crucial for managing anxiety and ensuring smooth induction.
- Traditional sedative agents may have drawbacks, necessitating evaluation of alternatives.
Purpose of the Study:
- To evaluate the efficacy of midazolam as a pediatric premedication compared to a combination of trimeprazine, droperidol, and methadone (TDM) and no sedation.
Main Methods:
- A randomized controlled trial involving 150 children aged 6 months to 5 years.
- Three groups received midazolam, TDM, or no sedative medication, respectively.
- Behavioral assessments were conducted in the holding room and during induction, with recovery times and temperature monitoring.
Main Results:
- Midazolam demonstrated superior behavioral patterns in the holding room compared to TDM and no sedation.
- Induction behavior was comparable across all groups.
- Recovery times were similar for midazolam and the unsedated group, but significantly prolonged in the TDM group.
- Body temperatures remained stable with midazolam and no sedation, but decreased with TDM.
Conclusions:
- Midazolam is a satisfactory premedication agent for pediatric patients, offering benefits in pre-anesthetic behavior without adverse effects on recovery or temperature.
- The TDM combination resulted in delayed recovery and hypothermia, suggesting it is less suitable for pediatric premedication.